Parion Sciences, Inc.
Records under this name other than the patents Parion Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,071,970 | Chloro-Pyrazine Carboxamide Derivatives with Epithelial Sodium Channel Blocking Activity Lapsed on the fee record Ended Sep 11, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 11, 2026 | Medium confidence |
| US 9,878,988 | Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity for the Treatment of Dry Eye and Other Mucosal Diseases Lapsed on the fee record Ended Jan 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Jan 30, 2026 | Medium confidence |
| US 8,575,176 | Heteroaromatic pyrazinoylguanidine sodium channel blockers Lapsed on the fee record Ended Nov 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2025 | From the USPTO record |
| US 7,410,968 | Capped pyrazinoylguanidine sodium channel blockers Term ended Term ended Oct 23, 2025 · From the USPTO record | Term ended | Term ended Oct 23, 2025 | From the USPTO record |
| US 8,551,534 | Inhaled hypertonic saline delivered by a heated nasal cannula Lapsed on the fee record Ended Oct 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 8, 2025 | From the USPTO record |
| US 7,368,451 | Capped pyrazinoylguanidine sodium channel blockers Term ended Term ended Aug 17, 2025 · From the USPTO record | Term ended | Term ended Aug 17, 2025 | From the USPTO record |
| US 9,695,134 | 3,5-Diamino-6-Chloro-N-(n-(4-Phenylbutyl)CARBAMIMIDOYL) PYRAZINE-2-Carboxamide COMPOUNDS Lapsed on the fee record Ended Jul 4, 2025 · Medium confidence | Lapsed on the fee record | Ended Jul 4, 2025 | Medium confidence |
| US 7,317,013 | Cyclic pyrazinoylguanidine sodium channel blockers Term ended Term ended May 13, 2025 · From the USPTO record | Term ended | Term ended May 13, 2025 | From the USPTO record |
| US 7,399,766 | Soluble amide & ester pyrazinoylguanidine sodium channel blockers Term ended Term ended May 8, 2025 · From the USPTO record | Term ended | Term ended May 8, 2025 | From the USPTO record |
| US 7,375,107 | Alaphatic pyrazinoylguanidine sodium channel blockers Term ended Term ended Apr 18, 2025 · From the USPTO record | Term ended | Term ended Apr 18, 2025 | From the USPTO record |